Skip to main content
. 2024 Feb 5;2024(2):CD015219. doi: 10.1002/14651858.CD015219.pub2

5.4. Analysis.

5.4

Comparison 5: Sensitivity analysis (excluding studies with an active comparator), Outcome 4: All adverse events